{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:10:15Z","timestamp":1759569015207,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3751,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.exphem.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T20:11:50Z","timestamp":1322079110000},"page":"216-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia"],"prefix":"10.1016","volume":"40","author":[{"given":"Michael A.","family":"Linden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy S.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Van Ness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2011.11.006_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(98)80005-1","article-title":"Signaling mechanisms through gp130: a model of the cytokine system","volume":"8","author":"Hirano","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.exphem.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","article-title":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","volume":"88","author":"Liu","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.1177","article-title":"High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis","volume":"18","author":"Bezieau","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.exphem.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/leu.2008.142","article-title":"Clinical and biological significance of RAS mutations in multiple myeloma","volume":"22","author":"Chng","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V97.3.729","article-title":"Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma","volume":"97","author":"Chesi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.onc.1206180","article-title":"An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth","volume":"22","author":"Crowder","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V81.10.2708.2708","article-title":"Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias","volume":"81","author":"Corradini","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular pathogenesis and a consequent classification of multiple myeloma","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/j.1460-2075.1990.tb07600.x","article-title":"Dissection of thymocyte signaling pathways by in\u00a0vivo expression of pertussis toxin ADP-ribosyltransferase","volume":"9","author":"Chaffin","year":"1990","journal-title":"Embo J"},{"key":"10.1016\/j.exphem.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood-2003-10-3399","article-title":"Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies","volume":"103","author":"Linden","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib12","first-page":"2268","article-title":"Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6","volume":"57","author":"Billadeau","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1093\/nar\/21.21.4941","article-title":"Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions","volume":"21","author":"Fulton","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1093\/nar\/22.20.4216","article-title":"Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers","volume":"22","author":"Fulton","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI200420369","article-title":"Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice","volume":"113","author":"Cheung","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/MCB.17.7.3477","article-title":"Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation","volume":"17","author":"O\u2019Brien","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1177\/002215549704501112","article-title":"Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer","volume":"45","author":"Lehr","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.exphem.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/j.1460-2075.1993.tb05812.x","article-title":"A dominant-negative transgene defines a role for p56lck in thymopoiesis","volume":"12","author":"Levin","year":"1993","journal-title":"Embo J"},{"key":"10.1016\/j.exphem.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.leukres.2004.09.007","article-title":"ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice","volume":"29","author":"Linden","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib21","first-page":"253","article-title":"Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl","volume":"4","author":"Langdon","year":"1989","journal-title":"Oncogene Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib22","first-page":"575","article-title":"Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations","volume":"4","author":"Alexander","year":"1989","journal-title":"Oncogene"},{"year":"2006","series-title":"Biology of Multiple Myeloma (Contemporary Cancer Research)","key":"10.1016\/j.exphem.2011.11.006_bib23"},{"key":"10.1016\/j.exphem.2011.11.006_bib24","first-page":"1178","article-title":"A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation","volume":"61","author":"Bazarov","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-1759(93)90004-Q","article-title":"Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene","volume":"160","author":"Shammah","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1073\/pnas.85.16.6067","article-title":"Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter\/enhancer-driven c-myc\/v-Ha-ras retrovirus","volume":"85","author":"Clynes","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.11.006_bib27","first-page":"297","article-title":"The transgenic window on\u00a0lymphoid malignancy","volume":"20","author":"Adams","year":"1989","journal-title":"Princess Takamatsu Symp"},{"key":"10.1016\/j.exphem.2011.11.006_bib28","first-page":"1023","article-title":"RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies","volume":"27","author":"Martin","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.exphem.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.2003.04664.x","article-title":"Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non-functional variant transcript","volume":"123","author":"Ng","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10428190500300969","article-title":"N-RAS and K-RAS gene mutations in Brazilian patients with multiple myeloma","volume":"47","author":"Ortega","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V98.5.1555","article-title":"Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation","volume":"98","author":"Kalakonda","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2004-03-0833","article-title":"Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors","volume":"105","author":"Rasmussen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Chng","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.exphem.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2003-01-0016","article-title":"Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis","volume":"102","author":"Davies","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"e2125","DOI":"10.1371\/journal.pone.0002125","article-title":"Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas","volume":"3","author":"Tran","year":"2008","journal-title":"PLoS One"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:18Z","timestamp":1759566558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11005790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0301472X11005790"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.11.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}